Clinical Challenges: Indolent Mantle Cell Lymphoma
(MedPage Today) -- Patients who present with indolent mantle cell lymphoma (MCL) have a better prognosis and can often defer treatment for months or sometimes years, but evidence on the best approach for this subgroup is sparse.
"Mantle cell lymphoma...
Read more »